Prostate Cancer Diagnosis and Treatment

Prostate cancer is the most commonly diagnosed solid-organ malignancy in men, and determining when and how aggressively to treat it remains one of medicine's most consequential judgment calls, because many tumors grow so slowly they will never cause harm while others prove fatal without swift intervention. Researchers rely on a combination of PSA screening, MRI-guided imaging, biopsy, and Gleason grading to distinguish indolent disease from high-risk disease, with treatment options ranging from active surveillance to surgery, radiation therapy, and androgen suppression. A central open question is how to reduce overdiagnosis and overtreatment without missing the cancers that genuinely need intervention, and long-term survival data are still maturing for newer approaches such as focal therapy and combination hormonal regimens. Genetic profiling is also reshaping how clinicians stratify risk and select therapies, pointing toward a more individualized standard of care that current clinical guidelines are only beginning to reflect.

Works

124,932

Total citations

1,979,485

Keywords

Prostate CancerScreeningRadiation TherapyGleason GradingMRI ImagingAndrogen Suppression